| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.12.2023 / 11:20 CET/CEST The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated a) Name | Title: | Prof. Dr. | | First name: | Andreas | | Last name(s): | Pahl | 2. Reason for the notification a) Position / status | Position: | Member of the managing body | b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name b) LEI 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code | Type: | Share | | ISIN: | DE000A11QVV0 | b) Nature of the transaction c) Price(s) and volume(s) | Price(s) | Volume(s) | | 3.3800 EUR | 676.00 EUR | | 3.3700 EUR | 3370.00 EUR | | 3.3800 EUR | 3042.00 EUR | | 3.3800 EUR | 1183.00 EUR | | 3.3800 EUR | 1859.00 EUR | d) Aggregated information | Price | Aggregated volume | | 3.3767 EUR | 10130.0000 EUR | e) Date of the transaction f) Place of the transaction
18.12.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
| Language: | English |
| Company: | Heidelberg Pharma AG |
| | Gregor-Mendel-Str. 22 |
| | 68526 Ladenburg |
| | Germany |
| Internet: | www.heidelberg-pharma.com |
| |
| End of News | EQS News Service |
88137 18.12.2023 CET/CEST
